Health
Johnson & Johnson starts human study of COVID-19 vaccine after promising monkey data – Reuters India
Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
(Reuters) – Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study p…
-
Noosa News13 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News12 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News12 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor
-
Business14 hours agoSolid superannuation gains continue to roll in